Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.48
-0.04 (-0.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Decoy Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3 | 4 | 3 | 3 | 3 | 22 | |
| Market Cap Growth | 178.08% | 56.21% | 3.58% | -26.55% | -84.43% | 3.40% | |
| Enterprise Value | -8 | -1 | -0 | -5 | -13 | -10 | |
| Last Close Price | 5.47 | 7.79 | 331.20 | 936.00 | 2203.20 | 17841.59 | |
| PS Ratio | - | - | - | - | - | 12.17 | |
| PB Ratio | 0.49 | 0.70 | 1.75 | 0.48 | 0.34 | 0.58 | |
| P/TBV Ratio | 0.49 | 0.70 | 1.75 | 0.48 | 0.34 | 0.75 | |
| Debt / Equity Ratio | - | - | 0.15 | 0.06 | - | - | |
| Net Debt / Equity Ratio | -1.82 | -1.82 | -1.46 | -1.06 | -1.17 | -0.75 | |
| Net Debt / EBITDA Ratio | 2.62 | 2.62 | 0.39 | 0.44 | 0.53 | 2.28 | |
| Net Debt / FCF Ratio | 2.22 | 2.22 | 0.49 | 0.44 | 0.69 | 2.86 | |
| Asset Turnover | - | - | - | - | - | 0.06 | |
| Quick Ratio | 2.07 | 2.07 | 1.61 | 4.54 | 3.22 | 13.84 | |
| Current Ratio | 2.13 | 2.13 | 1.98 | 5.02 | 3.40 | 14.29 | |
| Return on Equity (ROE) | -338.31% | -338.31% | -164.02% | -160.07% | -128.73% | -41.94% | |
| Return on Assets (ROA) | -36.36% | -36.36% | -74.59% | -75.90% | -51.76% | -24.35% | |
| Return on Capital Employed (ROCE) | -69.60% | -69.60% | -379.30% | -243.90% | -221.20% | -33.10% | |
| Earnings Yield | -429.82% | -302.23% | -210.28% | -489.96% | -906.85% | -57.02% | |
| FCF Yield | -165.74% | -116.54% | -170.66% | -501.81% | -504.82% | -45.55% | |
| Buyback Yield / Dilution | -20.93% | -20.93% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.